Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1100
Healthy volunteers: no

Brief summary:
This is a randomized, double-blind, multiple-site, placebo-controlled, parallel-group study, designed to compare the efficacy and safety of generic Clindamycin 1%/ Benzoyl peroxide 5% topical gel (Glenmark Generics, Ltd), and the marketed product BenzaClin® Topical Gel, Clindamycin 1%/ Benzoyl peroxide 5% (Valeant Pharmaceuticals, US) in the treatment of acne vulgaris.

Detailed description:

Arms:
arm 1: apply a thin layer of gel to the face arm 2: apply a thin layer of the gel to the face arm 3: apply a thin layer of the gel to the face

Interventions: intervention 1: Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel intervention 2: BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% intervention 3: Placebo
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: